FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Carlo Farina

Research Profile

Chemicals & Drugs

Concepts & Ideas

Structure-Activity Relationship

Anatomy

Living Beings

Physiology

Occupations

Drug Design

Procedures

Radioligand Assay

Co-author Network

Publications

TOP 3
Rosanna Supino; Anna Scovassi; Anna Cleta Croce; Laura Dal Bo; Enrica Favini; Alessandro Corbelli; Carlo Farina; Paola Misiano; Franco Zunino
Biological effects of a new vacuolar-H,-ATPase inhibitor in colon carcinoma cell lines.
Rosanna Supino; Giovanna Petrangolini; Graziella Pratesi; Monica Tortoreto; Enrica Favini; Laura Dal Bo; Patrizia Casalini; Enrico Radaelli; Anna Cleta Croce; Giovanni Bottiroli; Paola Misiano; Carlo Farina; Franco Zunino
Antimetastatic effect of a small-molecule vacuolar H+-ATPase inhibitor in in vitro and in vivo preclinical studies.
Giovanna Petrangolini; Rosanna Supino; Graziella Pratesi; Laura Dal Bo; Monica Tortoreto; Anna Cleta Croce; Paola Misiano; Pietro Belfiore; Carlo Farina; Franco Zunino
Effect of a novel vacuolar-H+-ATPase inhibitor on cell and tumor response to camptothecins.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Carlo Farina (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Rosanna Supino; Anna Scovassi; Anna Cleta Croce; Laura Dal Bo; Enrica Favini; Alessandro Corbelli; Carlo Farina; Paola Misiano; Franco Zunino
Biological effects of a new vacuolar-H,-ATPase inhibitor in colon carcinoma cell lines.
Annals of the New York Academy of Sciences 2009;1171():606-16.
2008: Rosanna Supino; Giovanna Petrangolini; Graziella Pratesi; Monica Tortoreto; Enrica Favini; Laura Dal Bo; Patrizia Casalini; Enrico Radaelli; Anna Cleta Croce; Giovanni Bottiroli; Paola Misiano; Carlo Farina; Franco Zunino
Antimetastatic effect of a small-molecule vacuolar H+-ATPase inhibitor in in vitro and in vivo preclinical studies.
The Journal of pharmacology and experimental therapeutics 2008;324(1):15-22.
2006: Giovanna Petrangolini; Rosanna Supino; Graziella Pratesi; Laura Dal Bo; Monica Tortoreto; Anna Cleta Croce; Paola Misiano; Pietro Belfiore; Carlo Farina; Franco Zunino
Effect of a novel vacuolar-H+-ATPase inhibitor on cell and tumor response to camptothecins.
The Journal of pharmacology and experimental therapeutics 2006;318(3):939-46.
2003: Barbara Biasotti; Sabrina Dallavalle; Lucio Merlini; Carlo Farina; Stefania Gagliardi; Carlo Parini; Pietro Belfiore
Synthesis of photoactivable inhibitors of osteoclast vacuolar ATPase.
Bioorganic & medicinal chemistry 2003;11(10):2247-54.
2001: F E Blaney; Luca F Raveglia; M Artico; S Cavagnera; C Dartois; Carlo Farina; Mario Grugni; Stefania Gagliardi; Mark A Luttmann; M Martinelli; GM Nadler; Carlo Parini; Paola Petrillo; Henry M Sarau; Mark A Scheideler; Douglas W P Hay; Giuseppe A M Giardina
Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.
Journal of medicinal chemistry 2001;44(11):1675-89.
2001: M R Boyd; Carlo Farina; Pietro Belfiore; Stefania Gagliardi; J W Kim; Y Hayakawa; J A Beutler; T C McKee; Barry J Bowman; Emma Jean Bowman
Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-atpases.
The Journal of pharmacology and experimental therapeutics 2001;297(1):114-20.
2001: Giulio Dondio; Silvio Ronzoni; Carlo Farina; D Graziani; Carlo Parini; Paola Petrillo; Giuseppe A M Giardina
Selective delta opioid receptor agonists for inflammatory and neuropathic pain.
Farmaco (Società chimica italiana : 1989) 2001;56(1-2):117-9.
2001: Carlo Farina; Stefania Gagliardi; GM Nadler; M Morvan; Carlo Parini; Pietro Belfiore; Luciano Visentin; Maxine Gowen
Novel bone antiresorptive agents that selectively inhibit the osteoclast V-H+-ATPase.
Farmaco (Società chimica italiana : 1989) 2001;56(1-2):113-6.
2000: Luciano Visentin; RA Dodds; M Valente; Paola Misiano; JN Bradbeer; S Oneta; X Liang; Maxine Gowen; Carlo Farina
A selective inhibitor of the osteoclastic V-H(+)-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats.
The Journal of clinical investigation 2000;106(2):309-18.
1999: Stefania Gagliardi; M Rees; Carlo Farina
Chemistry and structure activity relationships of bafilomycin A1, a potent and selective inhibitor of the vacuolar H+-ATPase.
Current medicinal chemistry 1999;6(12):1197-212.
1999: Giuseppe A M Giardina; M Artico; S Cavagnera; Alberto Cerri; E Consolandi; Stefania Gagliardi; D Graziani; Mario Grugni; Douglas W P Hay; Mark A Luttmann; R Mena; Luca F Raveglia; R Rigolio; Henry M Sarau; Dulcie B Schmidt; G Zanoni; Carlo Farina
Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists.
Farmaco (Società chimica italiana : 1989) 1999;54(6):364-74.
1999: Giuseppe A M Giardina; Luca F Raveglia; Mario Grugni; Henry M Sarau; Carlo Farina; Andrew D Medhurst; D Graziani; Dulcie B Schmidt; R Rigolio; Mark A Luttmann; S Cavagnera; James J Foley; V Vecchietti; Douglas W P Hay
Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).
Journal of medicinal chemistry 1999;42(6):1053-65.
1998: GM Nadler; M Morvan; I Delimoge; Pietro Belfiore; A Zocchetti; I James; DL Zembryki; E Lee-Rycakzewski; Carlo Parini; E Consolandi; Stefania Gagliardi; Carlo Farina
(2Z,4E)-5-(5,6-dichloro-2-indolyl)-2-methoxy-N-(1,2,2,6,6- pentamethylpiperidin-4-yl)-2,4-pentadienamide, a novel, potent and selective inhibitor of the osteoclast V-ATPase.
Bioorganic & medicinal chemistry letters 1998;8(24):3621-6.
1998: Stefania Gagliardi; P A Gatti; Pietro Belfiore; A Zocchetti; G D Clarke; Carlo Farina
Synthesis and structure-activity relationships of bafilomycin A1 derivatives as inhibitors of vacuolar H+-ATPase.
Journal of medicinal chemistry 1998;41(11):1883-93.
1998: Stefania Gagliardi; GM Nadler; E Consolandi; Carlo Parini; M Morvan; M N Legave; Pietro Belfiore; A Zocchetti; G D Clarke; I James; P Nambi; Maxine Gowen; Carlo Farina
5-(5,6-Dichloro-2-indolyl)-2-methoxy-2,4-pentadienamides: novel and selective inhibitors of the vacuolar H+-ATPase of osteoclasts with bone antiresorptive activity.
Journal of medicinal chemistry 1998;41(10):1568-73.
1998: Carlo Farina; M Pinza; G Pifferi
Synthesis and anti-ulcer activity of new derivatives of glycyrrhetic, oleanolic and ursolic acids.
Farmaco (Società chimica italiana : 1989) 1998;53(1):22-32.
1997: Giulio Dondio; Silvio Ronzoni; D S Eggleston; M Artico; Paola Petrillo; Giuseppe Petrone; L Visentin; Carlo Farina; V Vecchietti; G D Clarke
Discovery of a novel class of substituted pyrrolooctahydroisoquinolines as potent and selective delta opioid agonists, based on an extension of the message-address concept.
Journal of medicinal chemistry 1997;40(20):3192-8.
1997: Giuseppe A M Giardina; Henry M Sarau; Carlo Farina; Andrew D Medhurst; Mario Grugni; Luca F Raveglia; Dulcie B Schmidt; R Rigolio; Mark A Luttmann; V Vecchietti; Douglas W P Hay
Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework.
Journal of medicinal chemistry 1997;40(12):1794-807.
1996: Giuseppe A M Giardina; Henry M Sarau; Carlo Farina; Andrew D Medhurst; Mario Grugni; James J Foley; Luca F Raveglia; Dulcie B Schmidt; R Rigolio; M Vassallo; V Vecchietti; Douglas W P Hay
2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor.
Journal of medicinal chemistry 1996;39(12):2281-4.